Brief: Transgene And BioInvent Enrol First Patient In Phase I/IIa Of Oncolytic Virus BT-001 Trial
01/03/2021 07:11
March 1 (Reuters) - BIOINVENT INTERNATIONAL AB BINV.ST :
* TRANSGENE AND BIOINVENT HAVE ENROLLED FIRST PATIENT IN
PHASE
I/IIA TRIAL OF NOVEL ONCOLYTIC VIRUS BT-001 IN SOLID TUMORS
Source text for Eikon: ID:nBwb1RCm7a
Further company coverage: BINV.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))